Dr. Reddy's Laboratories Ltd. (RDY)
12.18
+0.02
(+0.16%)
USD |
NYSE |
Aug 28, 16:00
12.18
0.00 (0.00%)
Pre-Market: 20:00
Dr. Reddy's Laboratories Debt to Equity Ratio : 0.1877 for None
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.1877 |
| March 31, 2026 | 0.2051 |
| December 31, 2025 | 0.1819 |
| September 30, 2025 | 0.1633 |
| June 30, 2025 | 0.139 |
| March 31, 2025 | 0.1403 |
| December 31, 2024 | 0.1608 |
| September 30, 2024 | 0.159 |
| June 30, 2024 | 0.1041 |
| March 31, 2024 | 0.0714 |
| December 31, 2023 | 0.0741 |
| September 30, 2023 | 0.0523 |
| June 30, 2023 | 0.051 |
| March 31, 2023 | 0.0583 |
| December 31, 2022 | 0.0802 |
| September 30, 2022 | 0.0838 |
| June 30, 2022 | 0.1231 |
| March 31, 2022 | 0.1776 |
| December 31, 2021 | 0.1482 |
| September 30, 2021 | 0.1646 |
| June 30, 2021 | 0.1874 |
| March 31, 2021 | 0.1751 |
| December 31, 2020 | 0.1207 |
| September 30, 2020 | 0.1659 |
| June 30, 2020 | 0.1953 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.1426 |
| December 31, 2019 | 0.1098 |
| September 30, 2019 | 0.2051 |
| June 30, 2019 | 0.2352 |
| March 31, 2019 | 0.2738 |
| December 31, 2018 | 0.323 |
| September 30, 2018 | 0.4224 |
| June 30, 2018 | 0.4161 |
| March 31, 2018 | 0.401 |
| December 31, 2017 | 0.444 |
| September 30, 2017 | 0.4405 |
| June 30, 2017 | 0.4089 |
| March 31, 2017 | 0.3965 |
| December 31, 2016 | 0.4792 |
| September 30, 2016 | 0.5247 |
| June 30, 2016 | 0.3298 |
| March 31, 2016 | 0.2611 |
| December 31, 2015 | |
| September 30, 2015 | 0.3051 |
| June 30, 2015 | |
| March 31, 2015 | 0.3875 |
| December 31, 2014 | |
| September 30, 2014 | 0.3925 |
| June 30, 2014 | |
| March 31, 2014 | 0.4927 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Teva Pharmaceutical Industries Ltd. | 2.176 |
| Takeda Pharmaceutical Co., Ltd. | 0.6536 |
| Novo Nordisk A/S | 0.6333 |
| Perrigo Co. Plc | 1.375 |
| Innoviva, Inc. | 0.2187 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 6.078B |
| Total Liabilities (Quarterly) | 1.992B |
| Shareholders Equity (Quarterly) | 4.051B |
| Current Ratio | 1.902 |
| Net Debt Paydown Yield | -0.35% |